← Open Payments lookup

MAGGIE GORSKI: Open Payments

NPI 1144690819 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$423 in 21 payments from 12 companies in 2025. Trend: 2023 $541 · 2024 $1,042 · 2025 $423

Food & beverage: $423
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$83
E.R. Squibb & Sons, L.L.C.3$73
ABBVIE INC.2$54
Supernus Pharmaceuticals, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$41
Noven Therapeutics, LLC2$31
Axsome Therapeutics, Inc.1$25
Alkermes, Inc.1$21
Lundbeck LLC1$18
Collegium Pharmaceutical, Inc.1$14

Products named: REXULTI, COBENFY, VRAYLAR, Qelbree, TRINTELLIX, Xelstrym, Auvelity, ARISTADA.

Industry payments across TX — which companies pay providers there.